We are live on ! Find out more
MD icon

Pediatrix Medical

320 hedge funds and large institutions have $4.14B invested in Pediatrix Medical in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 109 increasing their positions, 117 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $5.45M | Put options by funds: $4.88M

6% more capital invested

Capital invested by funds: $3.91B → $4.14B (+$232M)

5% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 42

0.61% less ownership

Funds ownership: 95.5%94.89% (-0.61%)

1% less funds holding

Funds holding: 322320 (-2)

7% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 117

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
320
Holders Change
-2
Holders Change %
-0.62%
% of All Funds
7.31%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
44
Increased
109
Reduced
117
Closed
42
Calls
$5.45M
Puts
$4.88M
Net Calls
+$578K
Net Calls Change
-$3.93M
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
101
Paradigm Capital Management Inc
New York
$3.45M +$161K +3,500 +5%
NA
102
Neuburgh Advisers
California
$3.27M -$13.8M -300,014 -81%
Victory Capital Management
103
Victory Capital Management
Texas
$3.24M +$1.63M +35,497 +105%
MSL
104
Mackay Shields LLC
New York
$3.14M +$514K +11,191 +20%
CEI
105
Clark Estates Inc
New York
$3.14M +$115K +2,500 +4%
ASRS
106
Arizona State Retirement System
Arizona
$3.1M +$34.9K +760 +1%
SDIC
107
South Dakota Investment Council
South Dakota
$3.09M -$606K -13,200 -17%
FL
108
Fort LP
Maryland
$3.02M -$8.76M -190,915 -75%
TPSF
109
Texas Permanent School Fund
Texas
$2.74M -$100K -2,179 -4%
AWCI
110
Alpine Woods Capital Investors
New York
$2.72M -$4.59K -100 -0.2%
CF
111
CNA Financial
Illinois
$2.71M +$1.05M +22,873 +65%
MIM
112
MetLife Investment Management
New Jersey
$2.67M -$99.6K -2,169 -4%
State of Tennessee, Department of Treasury
113
State of Tennessee, Department of Treasury
Tennessee
$2.66M -$1.97M -43,000 -43%
Canada Life
114
Canada Life
Manitoba, Canada
$2.5M -$99.3K -2,163 -4%
GH
115
GAM Holding
Switzerland
$2.49M -$408K -8,896 -14%
Barclays
116
Barclays
United Kingdom
$2.47M +$941K +20,503 +63%
Tudor Investment Corp
117
Tudor Investment Corp
Connecticut
$2.47M +$1.12M +24,427 +86%
AG
118
Aperio Group
California
$2.47M -$175K -3,808 -7%
AllianceBernstein
119
AllianceBernstein
Tennessee
$2.46M -$36.3K -790 -1%
TI
120
Trexquant Investment
Connecticut
$2.45M +$1.33M +29,037 +123%
SEC
121
Seven Eight Capital
New York
$2.39M +$2.36M +51,306 New
MCIM
122
Meadow Creek Investment Management
Georgia
$2.38M -$10M -218,192 -81%
MSA
123
Mason Street Advisors
Wisconsin
$2.24M -$21.1K -460 -0.9%
BCC
124
Bridge City Capital
Oregon
$2.19M +$424K +9,232 +24%
RJA
125
Raymond James & Associates
Florida
$2.15M +$1.51M +32,977 +253%

MD Hedge Fund Activity: Q3 2018 in Review

320 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2018, worth a combined $4.14B — up 5.9% from $3.91B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new MD positions and 42 closed out — a net gain of 2 holders — while 109 added to existing stakes and 117 trimmed.

The largest buyer was Pzena Investment Management, adding an estimated $43.8M. The largest seller was Thompson Siegel & Walmsley, cutting an estimated $64.8M.

  • 320 institutional investors held Pediatrix Medical (MD) as of Q3 2018, down from 322 in Q2 2018.
  • Funds reported $4.14B of Pediatrix Medical stock for Q3 2018, up 5.9% quarter-over-quarter.
  • 44 funds opened new Pediatrix Medical positions in Q3 2018 and 42 closed out, a net change of +2 holders.
  • The largest Pediatrix Medical buyer in Q3 2018 was Pzena Investment Management, an estimated $43.8M added.
  • The largest Pediatrix Medical seller in Q3 2018 was Thompson Siegel & Walmsley, an estimated $64.8M sold.

Based on aggregated 13F filings for Q3 2018.